Pfizer Vaccine Less Effective in Ages 5 to 11, According to NY Study

Published on February 28, 2022

Two doses of the Pfizer Inc and BioNTech SE COVID-19 vaccine was protective against severe disease in children aged 5 to 11 during the recent omicron variant surge, but quickly lost most of its ability to prevent infection in the age group, according to a study by New York…

Read Full Article (External Site)